163 related articles for article (PubMed ID: 7031520)
1. [Action of MAP in adenocarcinoma of the endometrium. Clinical results and ultrastructural and histochemical study].
Pullè C; Rigano A
Minerva Ginecol; 1981 Oct; 33(10):937-54. PubMed ID: 7031520
[No Abstract] [Full Text] [Related]
2. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
[No Abstract] [Full Text] [Related]
3. [MAP in the therapy of adenocarcionoma of the endometrium. Immediate clinical results and general endocrine effects].
Ricciardi I; Calì A; Imparato E; Marino L; Pesando P
Minerva Ginecol; 1975 Sep; 27(9):744-53. PubMed ID: 1207966
[No Abstract] [Full Text] [Related]
4. [MAP in the treatment of adenocarcinoma of the endometrium].
Leone F; De Placido G; Frollo G
Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
[No Abstract] [Full Text] [Related]
5. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
[No Abstract] [Full Text] [Related]
6. [Medroxyprogesterone and endometrial adenocarcinoma].
Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
[No Abstract] [Full Text] [Related]
7. [Adenoacanthoma of the endometrium with extensive cellular mummification. Histological, histochemical and ultrastructural study].
Gloor E; Dessarzin D; Sadeghee S; Campiche M
Arch Anat Cytol Pathol; 1976; 24(6):459-61. PubMed ID: 1027373
[No Abstract] [Full Text] [Related]
8. [Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
Szarvas Z; Zsolnai B
Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):92-9. PubMed ID: 6717452
[No Abstract] [Full Text] [Related]
9. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
Cohen CJ; Deppe G; Bruckner HW
Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
Lanza A; Fedele M; Renzetti ME; Ferraris G
Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
[No Abstract] [Full Text] [Related]
11. Progestins in the treatment of endometrial carcinoma.
Anderson DG
Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
[No Abstract] [Full Text] [Related]
12. Evaluation of the mechanism of action of a progestin on endometrial andenocarcinoma.
Anderson DG
Surg Forum; 1969; 20():411-3. PubMed ID: 5376941
[No Abstract] [Full Text] [Related]
13. [Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Nishiya I; Izutsu T; Satoh K; Yoshizumi N; Kurokawa Y; Kagabu T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1161-8. PubMed ID: 3161958
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Ohta M; Takeda A; Ninagawa T; Tomoda Y
Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
[No Abstract] [Full Text] [Related]
15. [New technic of pre-surgical medical treatment of adenocarcinoma of the endometrium].
Martella E; Torella M; Messalli EM; Quirino R
Arch Ostet Ginecol; 1978; 83(3-4):81-91. PubMed ID: 757771
[No Abstract] [Full Text] [Related]
16. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
Horger EO; Williamson HO; Hester LL
J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
[No Abstract] [Full Text] [Related]
17. Chromatin analysis in human endometrial adenocarcinoma before and after treatment with 6-methyl-17-hydroxyprogesterone acetate (MPA).
Barni S; Novelli G; Zanoio L; Gerzeli G; Vecchietti G
Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 37(2):167-77. PubMed ID: 6115504
[No Abstract] [Full Text] [Related]
18. [Treatment of adenocarcinomas of the uterine body with medroxyprogesterone].
Bonte J; Drochmans A; Lassance M
Gynecol Obstet (Paris); 1966; 65(2):179-85. PubMed ID: 5942790
[No Abstract] [Full Text] [Related]
19. Cytochemistry of cell surface sialoglycoconjugates in endometrial adenocarcinoma. Effects of medroxyprogesterone therapy.
Barni S; Gerzeli G; Novelli G
Appl Pathol; 1984; 2(3):135-45. PubMed ID: 6544600
[TBL] [Abstract][Full Text] [Related]
20. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
Bonte J; Drochmans A; Ide P
Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
